Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q3 2021 · 10-Q
Revenue$413.40M$413.40M+52.3% vs Q3 2020 Net Income$41.98M$41.98M+21.9% vs Q3 2020 EPS Diluted$3.56$3.56+22.3% vs Q3 2020 Gross Profit$307,057,000+50.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$15,800,000−61.6% Free Cash Flowderived$5,411,000−85.7% Margins · derivedGross margin74.3%−0.9 pt vs Q3 2020
Operating margin13.3%−3.1 pt vs Q3 2020
Net margin10.2%−2.5 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 4, 2021 · 35 d after period end